Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1
- 25 October 2007
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 578 (2-3) , 171-176
- https://doi.org/10.1016/j.ejphar.2007.10.023
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Glutamate Transporter Subtypes EAAT4 and EAATs 1-3 Transport Glutamate with Dramatically Different Kinetics and Voltage Dependence but Share a Common Uptake MechanismThe Journal of general physiology, 2005
- Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouseNature Neuroscience, 2005
- Modulation of AMPA receptors in spinal motor neurons by the neuroprotective agent riluzoleJournal of Neuroscience Research, 2004
- Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- Glutamate uptakeProgress in Neurobiology, 2001
- A Novel Neuroprotective Mechanism of Riluzole: Direct Inhibition of Protein Kinase CNeurobiology of Disease, 2000
- ARACHIDONIC ACID INHIBITS3H-GLUTAMATE UPTAKE WITH DIFFERENT POTENCIES IN RODENT CENTRAL NERVOUS SYSTEM REGIONS EXPRESSING DIFFERENT TRANSPORTER SUBTYPESPharmacological Research, 1997
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosisAnnals of Neurology, 1995
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Comparative analysis of sodium‐dependent l‐glutamate transport of synaptosomal and astroglial membrane vesicles from mouse cortexFEBS Letters, 1992